Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-26 Purchase |
2025-03-28 8:57 pm |
Surrozen Inc. | SRZN | COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
1,034,482 | $11.6 | $11,999,991 | 2,817,866 (Indirect) |
View |
| 2025-03-05 Purchase |
2025-03-07 7:14 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
35,714,284 | $0.7 | $24,999,999 | 112,285,275 (Indirect) |
View |
| 2024-04-05 Sale |
2024-04-08 8:05 pm |
NGM BIOPHARMACEUTICALS INC | NGM | TCG Opportunity III GP LLC 10% Owner |
21,743,413 | $0 | $0 | 2,000 (Indirect Direct) |
View |
| 2024-02-12 Purchase |
2024-02-14 4:15 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
2,222,222 | $4.5 | $9,999,999 | 22,999,565 (Indirect) |
View |
| 2023-11-15 Purchase |
2023-11-17 4:33 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
22,631 | $0.6852 | $15,507 | 21,743,413 (Indirect Direct) |
View |
| 2023-03-10 Purchase |
2023-03-14 4:12 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) |
View |
| 2023-02-08 Purchase |
2023-02-10 4:32 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) |
View |
| 2023-01-30 Purchase |
2023-02-01 4:31 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
184,272 | $4.9986 | $921,110 | 21,720,782 (Indirect Direct) |
View |
| 2023-01-23 Purchase |
2023-01-25 4:38 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
9,900 | $4.9994 | $49,494 | 21,536,510 (Indirect Direct) |
View |
| 2023-01-19 Purchase |
2023-01-23 4:25 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) |
View |
| 2023-01-19 Purchase |
2023-01-23 4:25 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
38,139 | $4.9976 | $190,603 | 21,526,610 (Indirect Direct) |
View |
| 2023-01-17 Purchase |
2023-01-19 4:18 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) |
View |
| 2023-01-12 Purchase |
2023-01-17 4:36 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
5,378 | $4.9466 | $26,603 | 21,488,471 (Indirect Direct) |
View |
| 2023-01-10 Purchase |
2023-01-12 4:40 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
309,070 | $4.7865 | $1,479,359 | 21,483,093 (Indirect Direct) |
View |
| 2022-12-12 Purchase |
2022-12-14 4:31 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
300 | $4.9767 | $1,493 | 21,174,023 (Indirect Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:21 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
40,327 | $4.9988 | $201,588 | 21,173,723 (Indirect Direct) |
View |
| 2022-11-21 Purchase |
2022-11-23 4:12 pm |
Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
9,615,384 | $2.6 | $24,999,998 | 19,015,674 (Indirect) |
View |
| 2022-11-03 Purchase |
2022-11-07 4:30 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
139,148 | $4.9187 | $684,427 | 21,133,396 (Indirect Direct) |
View |
| 2022-10-27 Purchase |
2022-10-31 5:20 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
76,877 | $4.8602 | $373,638 | 20,994,248 (Indirect Direct) |
View |
| 2022-10-25 Purchase |
2022-10-27 6:58 pm |
NGM BIOPHARMACEUTICALS INC | NGM | COLUMN GROUP L P TCG Opportunity III GP LLC Director 10% Owner |
123,820 | $4.8088 | $595,428 | 20,917,371 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-26 Expired |
2025-03-28 8:57 pm |
N/A N/A |
Surrozen Inc. | SRZN | COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner |
1,904,070 | $0 | 2,817,866 (Indirect) |
View |
| 2024-04-05 Other |
2024-04-08 8:05 pm |
N/A N/A |
NGM BIOPHARMACEUTICALS INC | NGM | TCG Opportunity III GP LLC 10% Owner |
1,000 | $0 | 2,000 (Indirect) |
View |